Mark E. Dmytruk - 07 Mar 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
07 Mar 2024
Net transactions value
$0
Form type
4
Filing time
08 Mar 2024, 16:58:12 UTC
Previous filing
06 Mar 2024
Next filing
04 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Award +1,100,000 1,100,000 07 Mar 2024 Class A Common Stock 1,100,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 The RSUs vest in 48 equal monthly installments beginning on April 1, 2024.

Remarks:

Chief Financial Officer